{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:59:17Z","timestamp":1787021957359,"version":"build-2736575974"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135458","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T14:13:16Z","timestamp":1439475196000},"page":"e0135458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":106,"title":["The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer\u2019s but Not Parkinson\u2019s Disease or Dementia with Lewy Bodies"],"prefix":"10.1371","volume":"10","author":[{"given":"Malin","family":"Wennstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Surova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,13]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"2013 Alzheimer's disease facts and figures","volume":"9","author":"W Thies","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"MS Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"GM McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"RA Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"AJ Atkinson","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-8-20","article-title":"Fluid biomarkers in Alzheimer's disease\u2014current concepts","volume":"8","author":"C Rosen","year":"2013","journal-title":"Mol Neurodegener"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease","volume":"68","author":"R Craig-Schapiro","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2012-120787","article-title":"Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia","volume":"33","author":"B Olsson","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"e16032","DOI":"10.1371\/journal.pone.0016032","article-title":"Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease","volume":"6","author":"RJ Perrin","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-9-22","article-title":"Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics","volume":"9","author":"KR Wildsmith","year":"2014","journal-title":"Mol Neurodegener"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1055-9965.EPI-05-0011","article-title":"Serum YKL-40, a new prognostic biomarker in cancer patients?","volume":"15","author":"JS Johansen","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"D Bonneh-Barkay","year":"2010","journal-title":"J Neuroinflammation"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/neu.2010.1310","article-title":"YKL-40 expression in traumatic brain injury: an initial analysis","volume":"27","author":"D Bonneh-Barkay","year":"2010","journal-title":"J Neurotrauma"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3233\/JAD-132246","article-title":"Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies","volume":"40","author":"HM Nielsen","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"e53250","DOI":"10.1371\/journal.pone.0053250","article-title":"Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy","volume":"8","author":"M Wennstrom","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"IG McKeith","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"DJ Gelb","year":"1999","journal-title":"Arch Neurol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"B Mollenhauer","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref21","article-title":"Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease","author":"F Tateno","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2012-111655","article-title":"Altered CSF orexin and alpha-synuclein levels in dementia patients","volume":"29","author":"M Wennstrom","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation","volume":"22","author":"D Bonneh-Barkay","year":"2012","journal-title":"Brain Pathol"},{"issue":"3 Suppl","key":"ref24","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/j.jalz.2014.04.015","article-title":"The critical need for defining preclinical biomarkers in Alzheimer's disease","volume":"10","author":"MS Fiandaca","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"13","key":"ref25","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/mds.25589","article-title":"The glial marker YKL-40 is decreased in synucleinopathies","volume":"28","author":"B Olsson","year":"2013","journal-title":"Mov Disord"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12017-011-8147-9","article-title":"Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility","volume":"13","author":"N Mattsson","year":"2011","journal-title":"Neuromolecular Med"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-2009-1075","article-title":"Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease","volume":"17","author":"S Jesse","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Z Yang","year":"2015","journal-title":"Trends Neurosci"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1212\/01.wnl.0000191324.08289.9d","article-title":"Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration","volume":"66","author":"D Galimberti","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","article-title":"Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease","volume":"63","author":"D Galimberti","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"e30525","DOI":"10.1371\/journal.pone.0030525","article-title":"CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease","volume":"7","author":"K Westin","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"e0122000","DOI":"10.1371\/journal.pone.0122000","article-title":"Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica","volume":"10","author":"F Shimizu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1750-3639.2000.tb00248.x","article-title":"Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation","volume":"10","author":"D Stanimirovic","year":"2000","journal-title":"Brain Pathol"},{"issue":"12","key":"ref34","first-page":"8342","article-title":"Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors","volume":"7","author":"C Liu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1074\/jbc.M113.521161","article-title":"Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-kappaB signaling pathway and proinflammatory response in human pericytes","volume":"289","author":"I Guijarro-Munoz","year":"2014","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1742-2094-11-104","article-title":"A role for human brain pericytes in neuroinflammation","volume":"11","author":"D Jansson","year":"2014","journal-title":"J Neuroinflammation"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1128\/CMR.17.4.942-964.2004","article-title":"Role of microglia in central nervous system infections","volume":"17","author":"RB Rock","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1523\/JNEUROSCI.4689-06.2007","article-title":"Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis","volume":"27","author":"R Balabanov","year":"2007","journal-title":"J Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-2094-9-72","article-title":"A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi","volume":"9","author":"G Ramesh","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0306-4522(00)00024-5","article-title":"Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons","volume":"97","author":"CM Coughlan","year":"2000","journal-title":"Neuroscience"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1471-4159.1998.71031194.x","article-title":"Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat","volume":"71","author":"X Wang","year":"1998","journal-title":"J Neurochem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2009.06.081","article-title":"Inflammatory cytokines stimulate the chemokines CCL2\/MCP-1 and CCL7\/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]","volume":"1287","author":"WL Thompson","year":"2009","journal-title":"Brain Res"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1189\/jlb.72.5.847","article-title":"Multiple control of interleukin-8 gene expression","volume":"72","author":"E Hoffmann","year":"2002","journal-title":"J Leukoc Biol"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2007.07.009","article-title":"NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta","volume":"130","author":"FR Greten","year":"2007","journal-title":"Cell"},{"issue":"45","key":"ref45","doi-asserted-by":"crossref","first-page":"44058","DOI":"10.1074\/jbc.M306792200","article-title":"Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation","volume":"278","author":"M Rehli","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease","volume":"42","author":"A Antonell","year":"2014","journal-title":"J Alzheimers Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T00:25:03Z","timestamp":1691886303000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135458"}},"subtitle":[],"editor":[{"given":"David","family":"Bartres-Faz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,13]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,13]]}}}